Stallion India Fluorochemicals Ltd (STALLION) Q1FY27 Concall Summary - Jun-2026 Qtr
Performance Overview
- The company reported a positive start to FY27, with strong year-on-year growth in revenue, EBITDA, and PAT, indicating significant improvement in profitability.
- Management attributed the robust margin performance to a combination of a better product mix, particularly higher sales of HFOs, and strategic inventory planning which helped mitigate the impact of the Gulf crisis on logistics and pricing.
- Significant progress was made on key capital expenditure projects, including the completion of preparations for the high-purity helium processing plant at Akhalapur and continued work on the R-32 manufacturing facility at Bhilwara and the Mambattu-2 facility.
- The company is advancing its backward integration strategy with the R-32 plant, which is expected to reduce reliance on external sourcing, ensure supply reliability, and improve margins over time.
- Stallion India Fluorochemicals reiterated its strong growth guidance, projecting a 30-35% revenue CAGR over the next three years, coupled with an expected EBITDA margin improvement of 3-4% in the medium term.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.